GOWER BOB G Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$726,437.53
Insider Sells Quantity
9
Insider Sells Sum
$12.37M

Insider Activity of GOWER BOB G

According to the SEC Form 4 filings, GOWER BOB G, being in a position of

  1. director at Ensysce Biosciences, Inc.,
    оver the last 12 months, has bought 908614 shares for $444,169, and sold 0 shares,
    over all time since 2022-12-09, has bought 1735344 shares for $1.17M, and sold 0 shares.

Biography of GOWER BOB G

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$444,1692100
Sells
$000

Comparison of Insiders on Amount of Buys and Sells

2026-08-07PurchaseEnsysce Biosciences, Inc.
ENSC
director
400,000
5.5652%
$0.49$198,000-17.45%
2026-04-23PurchaseEnsysce Biosciences, Inc.
ENSC
director
508,614
6.2578%
$0.48$246,169-10.91%
2023-03-02PurchaseEnsysce Biosciences, Inc.
ENSC
director
90,287
0.6576%
$0.49$44,087-71.07%
2023-03-01PurchaseEnsysce Biosciences, Inc.
ENSC
director
270,000
2.1241%
$0.48$128,979-68.06%
2023-02-28PurchaseEnsysce Biosciences, Inc.
ENSC
director
109,300
0.8628%
$0.49$53,371-68.47%
2022-12-09PurchaseEnsysce Biosciences, Inc.
ENSC
director
357,143
19.2974%
$1.40$500,000-83.82%
2013-11-13SaleKirby Corporation
KEX
director
22,200
0.0385%
$92.08$2.04M+12.17%
2013-11-12SaleKirby Corporation
KEX
director
30,948
0.055%
$92.18$2.85M+14.71%
2012-02-09SaleKirby Corporation
KEX
director
25,892
0.0468%
$67.30$1.74M-13.94%
2012-02-08SaleKirby Corporation
KEX
director
1,600
0.0029%
$66.95$107,125-12.94%
2012-02-07SaleKirby Corporation
KEX
director
28,866
0.0521%
$66.99$1.93M-13.66%
2008-02-06SaleKirby Corporation
KEX
director
6,678
0.0125%
$47.04$314,106-4.27%
2008-02-04SaleKirby Corporation
KEX
director
51,390
0.0969%
$48.02$2.47M-5.36%
2007-11-28SaleKirby Corporation
KEX
director
10,000
0.0186%
$45.56$455,633+1.09%
2004-11-05SaleKirby Corporation
KEX
director
10,000
0.0402%
$44.91$449,138-0.41%
Total: 15
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.